Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04743414
Status:
COMPLETED
Last Update Posted:
2021-04-08
First Post:
2021-02-04
Brief Title:
Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects
Sponsor:
Concert Pharmaceuticals
Organization:
Concert Pharmaceuticals
Study Overview
Official Title:
A Phase 1 Open-Label Study to Assess the Effect of a Strong CYP3A4 Inhibitor Itraconazole on the Single Dose Pharmacokinetic Profile of CTP-543 in Healthy Adult Subjects
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 1 open-label study of the effect of itraconazole on the pharmacokinetics of CTP-543 in healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None